Clinical Trial Update: Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated temsirolimus in patients with metastatic or locally advanced recurrent endometrial cancer, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Adenocarcinoma
• Endometrial Adenosquamous Cell Carcinoma
• Endometrial Carcinoma
• Endometrial Carcinoma Stage Iiia
• Endometrial Carcinoma Stage Iiib
• Endometrial Carcinoma Stage Iiic
• Endometrial Clear Cell Carcinoma
• Endometrial Papillary Serous Carcinoma

Drugs mentioned

• Temsirolimus (temsirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2015-02-23